KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Pacific Biosciences Of California (PACB) over the last 7 years, with Q3 2025 value amounting to -$1.6 million.

  • Pacific Biosciences Of California's Other Operating Expenses fell 36006.39% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $440.9 million, marking a year-over-year increase of 33977.74%. This contributed to the annual value of $187.9 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Other Operating Expenses is -$1.6 million, which was down 36006.39% from -$1.8 million recorded in Q2 2025.
  • Pacific Biosciences Of California's 5-year Other Operating Expenses high stood at $353.2 million for Q1 2025, and its period low was -$54.8 million during Q3 2021.
  • Over the past 5 years, Pacific Biosciences Of California's median Other Operating Expenses value was $626000.0 (recorded in 2024), while the average stood at $25.5 million.
  • Over the last 5 years, Pacific Biosciences Of California's Other Operating Expenses had its largest YoY gain of 1598428.96% in 2025, and its largest YoY loss of 36006.39% in 2025.
  • Pacific Biosciences Of California's Other Operating Expenses (Quarter) stood at -$54.8 million in 2021, then skyrocketed by 103.71% to $2.0 million in 2022, then skyrocketed by 72.14% to $3.5 million in 2023, then surged by 2500.94% to $91.1 million in 2024, then crashed by 101.79% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q3 2025, -$1.8 million for Q2 2025, and $353.2 million during Q1 2025.